Raymond Hill

Dr. Raymond (Ray) Hill was previously a member of Addex's Board of Directors from the Annual General Meetings of 2008 until 2012. He is Visiting Professor of Pharmacology at Imperial College London, Chairman/Non-Executive Director of Avilex (Denmark) and a member of the Scientific Advisory Board of Neurosterix. He was previously Chair of the SAB of Asceneuron (2014-2021) and a Non-Executive Director of Orexo AB (2008-2019). Before retirement he was Executive Director, Licensing and External Research at Merck/MSD in Europe (2002-2008) and Executive Director, Pharmacology (1990-2002) at the Merck Neuroscience Research Centre, with oversight of neuroscience research at the Banyu Research Labs in Japan. He is President Emeritus of the British Pharmacological Society and a Fellow of the Academy of Medical Sciences. He received his academic training (BPharm, PhD) at the University of London and an Honorary DSc from the University of Bradford.

Director Compensation

You're subscribed.

Thanks for signing up.